CSA-Induced PRES after Heart Transplantation—Report of Two Cases and Review

Background Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disease possibly associated with the use of calcineurin inhibitors (CNI) like cyclosporine A. Case Description The case of a patient who developed severe PRES under CNI therapy shortly after heart transp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Katharina Huenges, Philipp Kolat, Bernd Panholzer, Assad Haneya
Formato: article
Lenguaje:EN
Publicado: Georg Thieme Verlag KG 2021
Materias:
Acceso en línea:https://doaj.org/article/6404fb2a242d4da4b5bb9bca7b846e2b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Background Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disease possibly associated with the use of calcineurin inhibitors (CNI) like cyclosporine A. Case Description The case of a patient who developed severe PRES under CNI therapy shortly after heart transplantation is presented here. Cerebral computed tomography led to the diagnose of PRES in our patient. New therapy strategy with a quadruple immunosuppressive protocol (cortisone, mycophenolate mofetil, low-dose CNI, and a mechanistic target of rapamycin inhibitor) was started. Conclusion Under the quadruple therapy, a neurologic recovery occurred. In PRES, the presented alternative therapy strategy may lead to improving neurological conditions and preserved transplant organ functions.